Related Experiment Videos
Peptides recognized by class I restricted T cells also bind to MHC class II molecules
J K Hickling1, C M Fenton, K Howland
1Laboratory of Molecular Immunology, Imperial Cancer Research Fund, London, UK.
International Immunology
|January 1, 1990
Summary
T cell determinants typically recognized by MHC class I can also bind to MHC class II molecules. This finding suggests broader antigen recognition capabilities for T cells, impacting immune response understanding.
Area of Science:
- Immunology
- Molecular Biology
- T cell biology
Background:
- T cell recognition mechanisms for MHC class I and II are similar.
- However, T cell determinants are often restricted to a single MHC class or few alleles.
- Potential structural differences between MHC class I and II restricted determinants are not fully understood.
Purpose of the Study:
- To investigate if MHC class I-restricted T cell determinants can bind to MHC class II molecules.
- To explore potential structural similarities or overlaps in antigen recognition between MHC class I and II pathways.
- To determine if peptides recognized by CD8+ T cells can interact with HLA-DR molecules.
Main Methods:
- Testing peptides previously identified as MHC class I restricted.
- Assessing peptide binding to HLA-DR molecules on B lymphoblastoid cell lines (B-LCL).
- Utilizing class II-negative B-LCL and transfected cell lines to confirm HLA-DR specificity.
Main Results:
- Four out of five tested MHC class I-restricted T cell determinants demonstrated binding to HLA-DR molecules on B-LCL.
- This binding was specifically inhibited by anti-HLA-DR monoclonal antibodies (mAb).
- Peptides did not bind to class II-negative cells but did bind to cells transfected with HLA-DR1.
Conclusions:
- MHC class I-restricted T cell determinants can bind to MHC class II molecules (HLA-DR).
- This suggests a potential overlap in the structural basis for T cell recognition across different MHC classes.
- Findings challenge the notion of strict MHC restriction and imply broader T cell epitope recognition.